Rifabutin pharmacokinetics and safety among TB/HIV-coinfected children receiving lopinavir/ritonavir-containing second-line ART

BACKGROUND: Treatment options are limited for TB/HIV-coinfected children who require PI-based ART. Rifabutin is the preferred rifamycin for adults on PIs, but the one study evaluating rifabutin with PIs among children was stopped early due to severe neutropenia. METHODS: We evaluated rifabutin safet...

詳細記述

保存先:
書誌詳細
出版年:J Antimicrob Chemother
主要な著者: Rawizza, Holly E, Oladokun, Regina, Ejeliogu, Emeka, Oguche, Stephen, Ogunbosi, Babatunde O, Agbaji, Oche, Odaibo, Georgina, Imade, Godwin, Olaleye, David, Wiesner, Lubbe, Darin, Kristin M, Okonkwo, Prosper, Kanki, Phyllis J, Scarsi, Kimberly K, McIlleron, Helen M
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2020
主題:
Original Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7879135/
https://ncbi.nlm.nih.gov/pubmed/33294914
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkaa512
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料